Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

por Jackson, Alice M, Jhund, Pardeep S, Anand, Inder S, Düngen, Hans-Dirk, Lam, Carolyn S P, Lefkowitz, Marty P, Linssen, Gerard, Lund, Lars H, Maggioni, Aldo P, Pfeffer, Marc A, Rouleau, Jean L, Saraiva, Jose F K, Senni, Michele, Vardeny, Orly, Wijkman, Magnus O, Yilmaz, Mehmet B, Saito, Yoshihiko, Zile, Michael R, Solomon, Scott D, McMurray, John J V
Publicado 2021

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-con...

por Vlaar, Alexander P J, Witzenrath, Martin, van Paassen, Pieter, Heunks, Leo M A, Mourvillier, Bruno, de Bruin, Sanne, Lim, Endry H T, Brouwer, Matthijs C, Tuinman, Pieter R, Saraiva, José F K, Marx, Gernot, Lobo, Suzana M, Boldo, Rodrigo, Simon-Campos, Jesus A, Cornet, Alexander D, Grebenyuk, Anastasia, Engelbrecht, Johannes M, Mukansi, Murimisi, Jorens, Philippe G, Zerbib, Robert, Rückinger, Simon, Pilz, Korinna, Guo, Renfeng, van de Beek, Diederik, Riedemann, Niels C
Publicado 2022